26-Oct-2026
158.69
+2.65 {+1.7 %}
V: 6,034,957
GILD
26-Oct-2026
Close: 158.69
+2.65 {+1.7 %}
Volume: 6,034,957
02-Oct-2026
05-Jun-2026
28-Mar-2024
31-Mar-2023
GILD
SPY
1.7
1.7
6.5
6.5
29.3
0.7
0.7
0.4
0.4
12.2
% Price Gain
WTD Performance (%)
MTD Performance (%)
QTD Performance (%)
YTD Performance (%)
SPY tracks S&P 500 index.
15 minute intraday candlestick chart, ~15 minute delay
15 minute intraday candlestick chart, ~15 minute delay
GILD News
23-Oct-2026 - Yahoo FinanceGilead Sciences (GILD) Could Be 22% Overvalued Following Its Liver Meeting Update Gilead Sciences (GILD) is back in focus after outlining new data it plans to showcase at The Liver Meeting 2026 on its liver ... 22-Oct-2026 - Yahoo FinanceGilead Sciences (GILD) vs. AMGN and VRTX: Can Oncology Growth and HIV Strength Drive a New Growth Era Beyond Acquisitions? Is GILD a good stock to buy? We came across a bullish thesis on Gilead Sciences, Inc. on Astute Optics – US’s Substack. In ... 21-Oct-2026 - Yahoo FinanceGilead Sciences (GILD) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release Gilead (GILD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. 19-Oct-2026 - Yahoo FinanceHow Investors Are Reacting To Gilead Sciences (GILD) FDA Drug Approvals Gilead Sciences recently secured multiple FDA decisions, including approval for the Bixlenvo HIV regimen, a label expansion ... 18-Oct-2026 - The Motley FoolGilead Sciences is on an FDA approval hot streak. Should you buy the stock like there's no tomorrow? The company's recent momentum continues unabated. 15-Oct-2026 - Yahoo FinanceGilead Sciences to Release Third Quarter 2026 Financial Results on Thursday, October 29, 2026 Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its third quarter 2026 financial results and guidance will be released on Thursday, October 29, 2026 after the market closes. At 4:30 p.m. 14-Oct-2026 - Yahoo FinanceWhat Does Gilead Sciences (GILD) Gain From Its New Solid Tumor Partnership? Gilead Sciences (NasdaqGS:GILD) announced a collaboration with Vir Biotechnology to develop novel T cell engagers for solid ... 12-Oct-2026 - BarchartEarnings preview: What to expect from Gilead Sciences’ report Gilead Sciences, Inc. (GILD), based in Foster City, California, has a market capitalization of approximately $187.4 billion. 11-Oct-2026 - Yahoo FinanceCan Gilead (GILD) Stock Continue Rising in 2027? Gilead Sciences, Inc. (NASDAQ:GILD) shares are up more than 24% this year, ahead of the S&P 500’s 14%. Gilead makes HIV, liver disease and cancer drugs. The stock is part of our coverage of the 8 best ...
More GILD News
Latest GILD Trades by Congress Members
6-MAY-2026 - Jared Moskowitz, FL (District 23) purchased between $1,001 and $15,000.THIS TRADE WAS FILED 19-JUN-2026.
6-MAY-2026 - Jared Moskowitz, FL (District 23) purchased between $1,001 and $15,000.THIS TRADE WAS FILED 19-JUN-2026.
27-JAN-2026 - Josh Gottheimer, NJ (District 5) purchased between $1,001 and $15,000.THIS TRADE WAS FILED 26-FEB-2026.
23-SEP-2025 - Valerie Hoyle, OR (District 4) sold between $1,001 and $15,000.THIS TRADE WAS FILED 10-OCT-2025.
6-JUN-2025 - Marjorie Taylor Greene, GA (District 14) purchased between $1,001 and $15,000.THIS TRADE WAS FILED 18-JUN-2025.
Latest GILD Trades by Congress Members
6-MAY-2026 - Jared Moskowitz, FL (District 23) purchased between $1,001 and $15,000.THIS TRADE WAS FILED 19-JUN-2026.
6-MAY-2026 - Jared Moskowitz, FL (District 23) purchased between $1,001 and $15,000.THIS TRADE WAS FILED 19-JUN-2026.
27-JAN-2026 - Josh Gottheimer, NJ (District 5) purchased between $1,001 and $15,000.THIS TRADE WAS FILED 26-FEB-2026.
23-SEP-2025 - Valerie Hoyle, OR (District 4) sold between $1,001 and $15,000.THIS TRADE WAS FILED 10-OCT-2025.
6-JUN-2025 - Marjorie Taylor Greene, GA (District 14) purchased between $1,001 and $15,000.THIS TRADE WAS FILED 18-JUN-2025.
More GILD Congress Trades
Disclaimer
Privacy
Contact
Copyright © 2001-2026, All rights reserved. HotCandlestick.com, LLC